Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study

These results indicate a lower pattern of FGA-LAI usage, reserved by prescribers for seemingly more difficult-to-treat patients and those least likely to adhere to oral medication.